Download PDF
Thromb Haemost 2017; 117(10): 2003-2005
DOI: 10.1160/TH17-03-0160
Letter to the Editor
Schattauer GmbH

Endothelial cell-specific overexpression of developmental endothelial locus-1 does not influence atherosclerosis development in ApoE-/- mice

Pallavi Subramanian
1   Institute for Clinical Chemistry and Laboratory Medicine, Medical Faculty, Technische Universität Dresden, Dresden, Germany
,
Marta Prucnal
1   Institute for Clinical Chemistry and Laboratory Medicine, Medical Faculty, Technische Universität Dresden, Dresden, Germany
,
Bettina Gercken
1   Institute for Clinical Chemistry and Laboratory Medicine, Medical Faculty, Technische Universität Dresden, Dresden, Germany
,
Matina Economopoulou
2   Department of Ophthalmology, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany
,
George Hajishengallis
3   Department of Microbiology, University of Pennsylvania, Penn Dental Medicine, Philadelphia, Pennsylvania, USA
,
Triantafyllos Chavakis
1   Institute for Clinical Chemistry and Laboratory Medicine, Medical Faculty, Technische Universität Dresden, Dresden, Germany
› Author Affiliations Financial support: This study was supported by grants from the Medical Faculty, Technische Universität Dresden (MeDDrive-Start-60347 to PS), from the Deutsche Forschungsgemeinschaft (SFB655 to TC) from the European Research Council (DEMETINL to TC) and from the US National Institutes of Health (DE026152 to GH and TC).
Further Information

Publication History

Received: 08 March 2017

Accepted after major revision: 21 July 2017

Publication Date:
08 November 2017 (online)

Also available at
    Permissions and Reprints

Supplementary Material to this article is available online at www.thrombosis-online.com.

 

  • References

  • 1 Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nature Med 2011; 17: 1410-1422.
    CrossrefPubMedGoogle Scholar
  • 2 Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol 2011; 12: 204-212.
    PubMedGoogle Scholar
  • 3 Tabas I, Garcia-Cardena G, Owens GK. Recent insights into the cellular biology of atherosclerosi. J Cell Biol 2015; 209: 13-22.
    CrossrefPubMedGoogle Scholar
  • 4 Weber C, Zernecke A, Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nature Rev Immunol 2008; 08: 802-815.
    CrossrefPubMedGoogle Scholar
  • 5 Viola J, Soehnlein O. Atherosclerosis – A matter of unresolved inflammation. Semin Immunol 2015; 27: 184-193.
    CrossrefPubMedGoogle Scholar
  • 6 Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nature Rev Immunol 2006; 06: 508-519.
    CrossrefPubMedGoogle Scholar
  • 7 Hidai C, Zupancic T, Penta K. et al. Cloning and characterization of developmental endothelial locus-1: an embryonic endothelial cell protein that binds the alphavbeta3 integrin receptor. Genes Dev 1998; 12: 21-33.
    CrossrefPubMedGoogle Scholar
  • 8 Chavakis T. Leucocyte recruitment in inflammation and novel endogenous negative regulators thereof. Eur J Clin Invest 2012; 42: 686-691.
    CrossrefPubMedGoogle Scholar
  • 9 Hajishengallis G, Chavakis T. Endogenous modulators of inflammatory cell recruitment. Trends Immunol 2013; 34: 1-6.
    CrossrefPubMedGoogle Scholar
  • 10 Hidai C, Kawana M, Kitano H. et al. Discoidin domain of Del1 protein contributes to its deposition in the extracellular matrix. Cell Tissue Res 2007; 330: 83-95.
    CrossrefPubMedGoogle Scholar
  • 11 Choi EY, Chavakis E, Czabanka MA. et al. Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science 2008; 322: 1101-1104.
    CrossrefPubMedGoogle Scholar
  • 12 Mitroulis I, Kang YY, Gahmberg CG. et al. Developmental endothelial locus-1 attenuates complement-dependent phagocytosis through inhibition of Mac-1-integrin. Thromb Haemost 2014; 111: 1004-1006.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nature Rev Immunol 2015; 15: 30-44.
    CrossrefPubMedGoogle Scholar
  • 14 Eskan MA, Jotwani R, Abe T. et al. The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nat Immunol 2012; 13: 465-473.
    CrossrefPubMedGoogle Scholar
  • 15 Shin J, Maekawa T, Abe T. et al. DEL-1 restrains osteoclastogenesis and inhibits inflammatory bone loss in nonhuman primates. Sci Transl Med 2015; 07: 307ra155.
    CrossrefPubMedGoogle Scholar
  • 16 Maekawa T, Hosur K, Abe T. et al. Antagonistic effects of IL-17 and D-resolvins on endothelial Del-1 expression through a GSK-3beta-C/EBPbeta pathway. Nature communications 2015; 06: 8272.
    CrossrefPubMedGoogle Scholar
  • 17 Tabas I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arteri Thromb Vasc Biol 2005; 25: 2255-2264.
    PubMedGoogle Scholar
  • 18 Littlewood TD, Bennett MR. Apoptotic cell death in atherosclerosis. Curr Opin Lipidol 2003; 14: 469-475.
    CrossrefPubMedGoogle Scholar
  • 19 Kakino A, Fujita Y, Nakano A. et al. Developmental Endothelial Locus-1 (Del-1) Inhibits Oxidized Low-Density Lipoprotein Activity by Direct Binding, and Its Overexpression Attenuates Atherogenesis in Mice. Circ J. 2016 Epub ahead of print.
    PubMedGoogle Scholar
  • 20 Kourtzelis I, Kotlabova K, Lim JH. et al. Developmental endothelial locus-1 modulates platelet-monocyte interactions and instant blood-mediated inflammatory reaction in islet transplantation. Thromb Haemost 2016; 115: 781-788.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
    CrossrefPubMedGoogle Scholar
  • 22 Nam D, Ni CW, Rezvan A. et al. Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis. Am J Physiol Heart Circ Physiol 2009; 297: H1535-H1543.
    CrossrefPubMedGoogle Scholar
  • 23 Freeley S, Kemper C, Le Friec G. The „ins and outs“ of complement-driven immune responses. Immunol Rev 2016; 274: 16-32.
    CrossrefPubMedGoogle Scholar